Sean Murphy - 27 Jan 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Jan 2025, 18:13:10 UTC
Prior SEC filing
14 Feb 2024
Next SEC filing
19 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Murphy

Key filing fact

Sean Murphy filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 29 Jan 2025.

Key facts

  • This page summarizes Sean Murphy's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 29 Jan 2025, 18:13.

Change

  • Previous filing in this sequence was filed on 14 Feb 2024.
  • Current net transaction value: +$157,200.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Award

Transaction value
$0
Shares
+12,500
Change %
+25%
Price
$0.000000
Shares after
63,288
Date
27 Jan 2025
Ownership
Direct
Footnotes
F1
TLSI transaction

Common Stock

Purchase

Transaction value
$79,650
Shares
+15,000
Change %
+8.9%
Price
$5.31
Shares after
182,732
Date
27 Jan 2025
Ownership
By Sean E Murphy TTEE U/A 2/4/2004
Footnotes
F2
TLSI transaction

Common Stock

Purchase

Transaction value
$77,550
Shares
+15,000
Change %
+8.2%
Price
$5.17
Shares after
197,732
Date
28 Jan 2025
Ownership
By Sean E Murphy TTEE U/A 2/4/2004
Footnotes
F3
TLSI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
357,535
Date
27 Jan 2025
Ownership
By Murphy Family Trust 2012
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TLSI transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+75,000
Change %
Price
$0.000000
Shares after
75,000
Date
27 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
75,000
Exercise price
$5.30
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.09 to $5.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.94 to $5.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F4

The Reporting Person's spouse has voting and investment discretion with respect to the shares held directly by Murphy Family Trust 2012 and thus the Reporting Person may be deemed to have beneficial ownership of the shares held directly by Murphy Family Trust 2012.

Footnote F5

One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service through each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .